Featured Research

from universities, journals, and other organizations

PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery

Date:
March 9, 2007
Source:
Memorial Sloan-Kettering Cancer Center
Summary:
A newly published study demonstrates that imaging with Positron Emission Tomography (PET) using a radiolabeled antibody accurately identifies whether a patient has clear cell renal carcinoma -- the most common and aggressive type of renal tumor -- and arms the urologist with crucial information that will help determine whether surgery is needed.

A newly published study demonstrates that imaging with Positron Emission Tomography (PET) using a radiolabeled antibody accurately identifies whether a patient has clear cell renal carcinoma -- the most common and aggressive type of renal tumor -- and arms the urologist with crucial information that will help determine whether surgery is needed.

Related Articles


Conducted by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC), the study will be published in The Lancet Oncology.

"This work represents the first prospective clinical trial to determine whether PET using a radiolabeled antibody is sensitive and specific enough to permit identification of clear cell renal carcinoma," said the study's lead author, Chaitanya Divgi, MD, who is now Chief of Nuclear Medicine and Clinical Molecular Imaging at the University of Pennsylvania.

In the study, the researchers used the radiolabeled monoclonal antibody G250, which was originally developed as a potential therapeutic agent by study co-author Lloyd J. Old, MD, Director of the New York Branch of the Ludwig Institute for Cancer Research (LICR), and an investigator at MSKCC. G250 has since been shown to target and bind to clear cell renal carcinoma and to react against an enzyme that is present in 94 percent of these cancers. Studies have also demonstrated that renal carcinoma has the highest recorded tumor uptake for G250 of any solid tumor, making the antibody ideal for use with PET imaging for this disease.

PET is a highly specialized, noninvasive imaging technique that uses short-lived radioactive substances to produce three-dimensional color images of those substances functioning within the body. Unlike CT (computerized tomography) and MRI (magnetic resonance imaging), which provide anatomic images, PET scanning provides information about the body's chemistry, metabolic activity, and body function not available through other procedures.

According to the study, 15 out of 16 clear cell renal carcinomas were correctly identified using G250 PET, resulting in a sensitivity of 94 percent. All 9 patients with non-clear cell renal masses were negative on the PET scan -- which is highly predictive of a less aggressive cancer -- resulting in a specificity of 100 percent.

"Antibody PET could end up changing the standard of care for patients with kidney cancer," said the study's senior author, Paul Russo, MD, a urologic cancer surgeon at MSKCC. "The excellent sensitivity and specificity of this tool supports the utility of G250 PET imaging in the work-up and management strategies for clinically localized renal masses and as an alternative to biopsy for distinguishing renal lesions."

In the study, 25 patients scheduled to have surgery to remove a renal mass received intravenous 124I-cG250. PET images obtained prior to surgery were graded as positive or negative for antibody uptake. A pathologist unaware of PET scan results then classified resected tumor specimens as clear cell renal carcinoma or otherwise.

All patients were monitored for toxicity and the antibody infusion was well tolerated with no side effects or other adverse events related to the agent.

According to the authors, G250 PET may ultimately be used not only to determine the aggressiveness and extent of a patient's disease prior to any surgical intervention, but also to measure the therapeutic effects of a particular treatment, and predict the likelihood of recurrence.

"The promising results of this trial have stimulated interest in a larger, prospective multi-center trial to confirm our findings, and ultimately greatly improve the clinical management of patients with kidney tumors," said Dr. Divgi.

There were an estimated 38,890 new cases of renal carcinoma in the United States in 2006, and an estimated 12,840 deaths due to the disease. The majority of cases of renal tumors are confined to the kidney and 30 percent of patients either present with, or later develop, metastatic disease. Of those patients who either present with or later develop metastatic renal cancer, approximately 90 percent of these tumors have the most common clear cell histological subtype when examined under a microscope.


Story Source:

The above story is based on materials provided by Memorial Sloan-Kettering Cancer Center. Note: Materials may be edited for content and length.


Cite This Page:

Memorial Sloan-Kettering Cancer Center. "PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery." ScienceDaily. ScienceDaily, 9 March 2007. <www.sciencedaily.com/releases/2007/03/070307075512.htm>.
Memorial Sloan-Kettering Cancer Center. (2007, March 9). PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery. ScienceDaily. Retrieved November 22, 2014 from www.sciencedaily.com/releases/2007/03/070307075512.htm
Memorial Sloan-Kettering Cancer Center. "PET Imaging Identifies Aggressive Kidney Cancers That Require Surgery." ScienceDaily. www.sciencedaily.com/releases/2007/03/070307075512.htm (accessed November 22, 2014).

Share This


More From ScienceDaily



More Matter & Energy News

Saturday, November 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Toyota's Hydrogen Fuel-Cell Green Car Soon Available in the US

Toyota's Hydrogen Fuel-Cell Green Car Soon Available in the US

AFP (Nov. 21, 2014) Toyota presented its hydrogen fuel-cell compact car called "Mirai" to US consumers at the Los Angeles auto show. The car should go on sale in 2015 for around $60.000. It combines stored hydrogen with oxygen to generate its own power. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Google Announces Improvements To Balloon-Borne Wi-Fi Project

Google Announces Improvements To Balloon-Borne Wi-Fi Project

Newsy (Nov. 21, 2014) In a blog post, Google said its balloons have traveled 3 million kilometers since the start of Project Loon. Video provided by Newsy
Powered by NewsLook.com
NSA Director: China Can Damage US Power Grid

NSA Director: China Can Damage US Power Grid

AP (Nov. 20, 2014) China and "one or two" other countries are capable of mounting cyberattacks that would shut down the electric grid and other critical systems in parts of the United States, according to Adm. Michael Rogers, director of the National Security Agency and hea Video provided by AP
Powered by NewsLook.com
Latest Minivan Crash Tests Aren't Pretty

Latest Minivan Crash Tests Aren't Pretty

Newsy (Nov. 20, 2014) Five minivans were put to the test in head-on crash simulations by the Insurance Institute for Highway Safety. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins